Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2938)	4/19/2011 3:47:41 PM
From: Jibacoa	Respond to of 3722

It seems that the insiders and others that bough SNTA stock at $4.89 on the $35M private stock placement bought the stock at a good price.<g The stock opened today with a small UG bigcharts.marketwatch.com SNTA sold 7.2 million shares of common stock at $4.89 per share,which was Thursday’s closing price. SNTA said that 22% of the shares were bought by insiders and the balance was purchased by institutional investors. No underwriter or placement agent was involved. <g> The ACTAY has been increased to $7 <g> The insiders hold a good % of the float and SNTA has a good amount of cash, but it has burning the cash at a good clip and the stock has a good amount of resistance at the $6 level. bigcharts.marketwatch.com Bernard